SG Americas Securities
KALA icon

SG Americas Securities’s KALA BIO KALA Stock Holding History

SG Americas Securities’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-207
Closed -$6K – 3468
2025
Q4 		$6K Buy
+207
New +$9.27K ﹤0.01% 3537
2021
Q4 		– Sell
-10
Closed -$66K – 3603
2021
Q3 		$66K Buy
+10
New +$86.3K ﹤0.01% 3710
2020
Q3 		– Sell
-9
Closed -$236K – 3074
2020
Q2 		$236K Buy
+9
New +$255K ﹤0.01% 2717

Other funds holding KALA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Americas Securities's KALA Position: Q1 2026 in Review

SG Americas Securities sold out of KALA BIO (KALA) in Q1 2026, closing a stake of 207 shares — an estimated $6K sold.

SG Americas Securities first reported a position in KALA in Q2 2020 and held it in 3 quarters. The position peaked at $236K in Q2 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • SG Americas Securities reported no remaining KALA BIO position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 207 KALA BIO shares in Q1 2026, an estimated $6K.
  • SG Americas Securities first reported a position in KALA BIO in Q2 2020 and held it in 3 quarters.
  • SG Americas Securities's KALA BIO position peaked at $236K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.